Cambridge, Massachusetts
January 13, 2009
Verenium Corporation (Nasdaq: VRNM), a pioneer in the
development of next-generation cellulosic ethanol and
high-performance specialty enzymes, announced today that it has
regained compliance with the continued listing requirements of
The NASDAQ Global Market. NASDAQ previously notified Verenium
that it had fallen out of compliance with NASDAQ Marketplace
Rule 4450(b)(1)(A), requiring listed companies on the NASDAQ
Global Market to maintain a minimum market capitalization of $50
million. NASDAQ has confirmed that the Company now meets the
requirements of this rule.
Verenium Corporation is a leader in the development and
commercialization of cellulosic ethanol, an
environmentally-friendly and renewable transportation fuel, as
well as high-performance specialty enzymes for applications
within the biofuels, industrial, and health and nutrition
markets. The Company possesses integrated, end-to-end
capabilities in pre-treatment, novel enzyme development,
fermentation, engineering, and project development and is moving
rapidly to commercialize its proprietary technology for the
production of ethanol from a wide array of feedstocks, including
sugarcane bagasse, dedicated energy crops, agricultural waste,
and wood products. In addition to the vast potential for
biofuels, a multitude of large-scale industrial opportunities
exist for the Company for products derived from the production
of low-cost, biomass-derived sugars.
Verenium's Specialty Enzyme business harnesses the power of
enzymes to create a broad range of specialty products to meet
high-value commercial needs. Verenium's world class R&D
organization is renowned for its capabilities in the rapid
screening, identification, and expression of enzymes-proteins
that act as the catalysts of biochemical reactions. |
|
